Overview
SONM market data
Price History
SONM price chart · 1M
- O
- 3.04
- H
- 3.04
- L
- 3.00
- C
- 3.00
- Vol
- 372.00
- Source
- US equities market feed
- Observed
- Aug 27, 2026, 12:00 AM
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & Performance
- Open
- $3.04
- Previous Close
- $3.29
- Day High
- $3.04
- Day Low
- $3.00
- 52 Week High
- $5.93
- 52 Week Low
- $2.83
- 7 Day Return
- -10.18%
- 30 Day Return
- -2.28%
- 90 Day Return
- -32.13%
- 1 Year Return
- -26.65%
- Daily Notional Volume
- $1.1K Latest daily bar volume multiplied by its closing price.
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$28.58 Diluted earnings per share over the trailing twelve months.
- Beta
- 1.67 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -56.5% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $2.52 – $16.97 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $5M · P/B 1.42 · P/S 0.09.
Company News
8-K filing — DNA X, Inc. (SONM)SEC EDGAR · Aug 27, 2026, 11:32 AM
DNA X Says Expects Revenue From Trading Platform To Begin Towards End Of Q3 2026 Or Beginning Of Q4 2026Benzinga · Aug 19, 2026, 8:21 PM
DNA X Q2 EPS $(0.91) Up From $(14.15) YoYBenzinga · Aug 19, 2026, 8:18 PM
12 Information Technology Stocks Moving In Monday's After-Market SessionBenzinga · Aug 17, 2026, 9:06 PM
8-K/A filing — DNA X, Inc. (SONM)SEC EDGAR · Jul 9, 2026, 8:05 PM
DNA X Announces $8.1M Private Placement Of 1.35M Series B Preferred Shares At $6.00/Share, Including $5M Cash And $3.1M Debt CancellationBenzinga · Jul 2, 2026, 1:05 PM